Gugler R, Höbel W, Bodem G, Dengler H J
Clin Pharmacol Ther. 1975 Feb;17(2):127-33. doi: 10.1002/cpt1975172127.
The correlation between the beta receptor blocking activity of pindolol and plasma level was studied in 8 subjects after a 10-mg oral dose. Exercise tachycardia was markedly reduced over a period of at least 6 hr. Significant effects were recorded 30 min after the drug. For each individual there was a close correlation between log plasma level and beta blockade. The regression lines were parallel as shown by analysis of covariance; the intercepts, however, were significantly different. It can be concluded that there is a correlation between plasma level and beta adrenergic blockade by pindolol, but the data failed to establish in different individuals the blood levels necessary to achieve effective adrenergic blockade.
在8名受试者口服10毫克剂量的吲哚洛尔后,研究了其β受体阻断活性与血浆水平之间的相关性。运动性心动过速在至少6小时内显著降低。用药后30分钟记录到显著效果。对于每个个体,血浆水平对数与β受体阻断之间存在密切相关性。协方差分析表明回归线是平行的;然而,截距有显著差异。可以得出结论,吲哚洛尔的血浆水平与β肾上腺素能阻断之间存在相关性,但数据未能确定不同个体达到有效肾上腺素能阻断所需的血药浓度。